Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Eva Versteijne(Cancer Center Amsterdam), Gabriel Paardekooper(Radboud University Nijmegen), Mustafa Suker(Erasmus MC Cancer Institute), Casper H.J. van Eijck(Erasmus MC), Maurice J.C. van der Sangen(Radboud University Nijmegen), Karen J. Neelis, Marc G. Besselink(Amsterdam Neuroscience), Emile D. Kerver(OLVG), Geert-Jan Creemers, Jeroen Buijsen(Maastricht University Medical Centre), Jan Willem B. de Groot(Isala), Bas Groot Koerkamp, Judith de Vos‐Geelen(Maastricht University Medical Centre), Geertjan van Tienhoven, Olivier R. Busch(Amsterdam Neuroscience), Ronald M. van Dam(Maastricht University Medical Centre), Gijs A. Patijn(Isala), Cornelis J.A. Punt(Utrecht University), Aeilko H. Zwinderman(Amsterdam Neuroscience), Bert A. Bonsing(Leiden University Medical Center), Saskia Luelmo(Leiden University Medical Center), Karin Groothuis(Netherlands Comprehensive Cancer Organisation), Jeanin E. van Hooft(Leiden University Medical Center), Ignace H. J. T. de Hingh(Radboud University Nijmegen), Marjolein Y.V. Homs(Erasmus MC Cancer Institute), Janine M. Akkermans-Vogelaar(Netherlands Comprehensive Cancer Organisation), Sebastiaan Festen(OLVG), Joost J. Nuyttens(Erasmus MC Cancer Institute), Johanna W. Wilmink, Ferry A.L.M. Eskens(Erasmus MC)
Journal of Clinical Oncology
February 27, 2020
Cited by 1,071


Related Papers